Original languageEnglish
Pages (from-to)165-174
Number of pages10
JournalPharmaceutical Chemistry Journal
Volume51
Issue number3
DOIs
Publication statusPublished - Jun 2017

    Research areas

  • Cardioprotection, Cardiovascular system, Hybrid compounds, Hydrogen sulfide, Organic HS donors, cardiovascular system, EFFECTS IN-VITRO, PLATELET-AGGREGATION, MUSCLE-CELL PROLIFERATION, MYOCARDIAL-ISCHEMIA, MEDIATES CARDIOPROTECTION, hybrid compounds, ISCHEMIA-REPERFUSION INJURY, H2S DONORS, S-PROPARGYL-CYSTEINE, hydrogen sulfide, organic H2S donors, cardioprotection, NITRIC-OXIDE, PHARMACOLOGICAL EVALUATION

    OECD FOS+WOS

ID: 10183903